Francesco Pantano

Has grant

National Academic Qualification as Full Professor (Abilitazione Scientifica Nazionale a Professore di I Fascia) in Hematology, Oncology and Rheumatology (MED 06/D3)

Ministero dell’Istruzione, dell’Università e della Ricerca

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Medical Imaging Medical Imaging professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Francesco Pantano holds the position of Associate Professor at the Ministero dell'Università e della Ricerca in Italy. His research areas include hematology, oncology, and rheumatology, with recent publications focusing on stereotactic radiotherapy for metastatic breast cancer, immunotherapy advancements for lung cancer, and the effects of COVID-19 on cancer patients. He has also explored methodologies for predicting occult nipple involvement in breast cancer and the biological effects of CDK inhibitors on the bone microenvironment in breast cancer.

Recent Grants

Grant: Close

Scientific Fellowship

Open Date: 2015-01-01

Close Date: 2015-12-01

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Sara Ramella

Associate Professor

Università Campus Bio-Medico di Roma

ITALY

View details

eriseld krasniqi

ITALY

View details

Carlo Cosimo Quattrocchi

Università Campus Bio-Medico di Roma

ITALY

View details

Michele Fiore

Università Campus Bio-Medico di Roma

ITALY

View details

Cian Murphy

The Francis Crick Institute

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Francesco Pantano

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (10)

BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry

The Role of the CDK4/6 Inhibitor Ribociclib in Locally Advanced and Oligometastatic Hormone Receptor Positive, Her2 Negative, Advanced Breast Cancer: Case Series and Review of the Literature

Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors.

Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach.

Preoperative Ultrasound-guided Sub-areolar Biopsy in Predicting Occult Nipple Involvement in Breast Cancer Patients: Proposal for a Methodological Approach

Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment.

Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series.

Changes in bone turnover markers in patients without bone metastases receiving immune checkpoint inhibitors: An exploratory analysis

Collaborators (5)

Sara Ramella

eriseld krasniqi

Carlo Cosimo Quattrocchi

Michele Fiore

Cian Murphy

Make your next move.